CorQuest MedTech: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CorQuest MedTech
Largest movements
- Intangible fixed assets -€136,615
down €136,615 (-17.8%), from €766,776 to €630,161
- Cash -€66,671
down €66,671 (-61.5%), from €108,463 to €41,792
mainly Net result for the year (-€194,609) and Investment in fixed assets (net) (-€50,753)
- Receivables within one year -€46,831
down €46,831 (-95.1%), from €49,270 to €2,439
of which Trade receivables: -€38,454
- Profit (loss) carried forward -€194,609
down €194,609 (-103.2%), from -€188,620 to -€383,229
- Trade debts -€42,616
down €42,616 (-87.7%), from €48,576 to €5,960
- Tax, wage and social debts -€12,971
no longer reported in 2025 (was €12,971)
- Depreciation +€84,095
up €84,095 (+81.4%), from €103,273 to €187,368
- Staff costs -€68,381
down €68,381 (-75.7%), from €90,368 to €21,986
- Gross operating margin -€13,612
down €13,612 (-42.4%), from €32,088 to €18,476
- Financial income -€2,789
down €2,789 (-95.4%), from €2,924 to €135
- Other operating charges +€1,132
up €1,132 (+64.5%), from €1,755 to €2,887
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €925,089 | €675,137 | -€249,951 | -27.0% |
| Fixed assets | 21/28 | €766,776 | €630,161 | -€136,615 | -17.8% |
| Intangible fixed assets | 21 | €766,776 | €630,161 | -€136,615 | -17.8% |
| Current assets | 29/58 | €158,312 | €44,976 | -€113,336 | -71.6% |
| Amounts receivable within one year | 40/41 | €49,270 | €2,439 | -€46,831 | -95.1% |
| Trade receivables | 40 | €38,814 | €359 | -€38,454 | -99.1% |
| Other amounts receivable | 41 | €10,456 | €2,079 | -€8,377 | -80.1% |
| Cash at bank and in hand | 54/58 | €108,463 | €41,792 | -€66,671 | -61.5% |
| Deferred charges and accrued income | 490/1 | €580 | €745 | +€166 | +28.6% |
| Total equity and liabilities | 10/49 | €925,089 | €675,137 | -€249,951 | -27.0% |
| Equity | 10/15 | €747,380 | €552,771 | -€194,609 | -26.0% |
| Contributions | 10/11 | €936,000 | €936,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€188,620 | -€383,229 | -€194,609 | -103.2% |
| Amounts payable | 17/49 | €177,709 | €122,366 | -€55,343 | -31.1% |
| Amounts payable within one year | 42/48 | €176,592 | €121,258 | -€55,334 | -31.3% |
| Trade debts | 44 | €48,576 | €5,960 | -€42,616 | -87.7% |
| Suppliers | 440/4 | €48,576 | €5,960 | -€42,616 | -87.7% |
| Taxes, remuneration and social security | 45 | €12,971 | - | -€12,971 | |
| Remuneration and social security | 454/9 | €12,971 | - | -€12,971 | |
| Other amounts payable | 47/48 | €115,045 | €115,298 | +€253 | +0.2% |
| Accrued charges and deferred income | 492/3 | €1,116 | €1,108 | -€9 | -0.8% |
| Remuneration, social security and pensions | 62 | €90,368 | €21,986 | -€68,381 | -75.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €103,273 | €187,368 | +€84,095 | +81.4% |
| Other operating charges | 640/8 | €1,755 | €2,887 | +€1,132 | +64.5% |
| Gross operating margin | 9900 | €32,088 | €18,476 | -€13,612 | -42.4% |
| Operating profit (loss) | 9901 | -€163,307 | -€193,765 | -€30,458 | -18.7% |
| Financial income | 75/76B | €2,924 | €135 | -€2,789 | -95.4% |
| Recurring financial income | 75 | €2,924 | €135 | -€2,789 | -95.4% |
| Financial charges | 65/66B | €1,100 | €979 | -€121 | -11.0% |
| Recurring financial charges | 65 | €1,100 | €979 | -€121 | -11.0% |
| Profit (loss) for the period before taxes | 9903 | -€161,483 | -€194,609 | -€33,126 | -20.5% |
| Income taxes | 67/77 | €755 | - | -€755 | |
| Profit (loss) for the period | 9904 | -€162,238 | -€194,609 | -€32,370 | -20.0% |
| Profit (loss) for the period to be appropriated | 9905 | -€162,238 | -€194,609 | -€32,370 | -20.0% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.